Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended December 31, 2013: The Unaudited results for the Quarter ended December 31, 2013 The Company has posted a net profit of Rs. 858.80 million for the quarter ended December 31, 2013 where as the same was at Rs. 742.20 million for the quarter ended December 31, 2012. Total Income is Rs. 7596.30 million for the quarter ended December 31, 2013 where as the same was at Rs. 9103.60 million for the quarter ended December 31, 2012. "Other Operating Income for the nine months ended December 31, 2012 and year ended March 31, 2013 mainly represents Income from Partnership Firms. With effect from August 31, 2012, these Partnership Firms have been converted under Part IX of the Companies Act, 1956 into Private Limited companies, being wholly owned subsidiaries of the Company and accordingly, the figures for nine months ended December 31, 2013 are not comparable with the corresponding figures for nine months ended December 31, 2012." The Consolidated Results are as follows : The Unaudited results for the Quarter ended December 31, 2013 The Group has posted a net profit after taxes and minority interest of Rs. 15310.90 million for the quarter ended December 31, 2013 where as the same was at Rs. 8813.00 million for the quarter ended December 31, 2012. Total Income is Rs. 44468.20 million for the quarter ended December 31, 2013 where as the same was at Rs. 29333.30 million for the quarter ended December 31, 2012. "The Scheme of Arrangement in the nature of spin off and transfer of Domestic Formulation undertaking of the Company to Sun Pharma Laboratories Ltd., wholly owned subsidiary, from the close of the business hours on March 31, 2012, being the appointed date, was approved by the Honble High Courts of Gujarat and Bombay vide their Orders dated May 03, 2013 and the said Scheme became effective from May 27, 2013 upon filing of the said Orders with the Registrar of Companies. Accordingly, the effect of the Scheme was given in the financial results for the year ended March 31, 2013 only on an annual basis and approved by the Board of Directors at their meeting held on May 28, 2013. However, the financial results for quarterly periods during the year ended March 31, 2013 had been so approved without giving effect to the said Scheme and have not been restated in these results. In view of this, the figures for the quarter and nine months ended December 31, 2013 are not comparable with the figures for the quarter and nine months ended December 31, 2012 due to effect of spin off and transfer of Domestic Formulation undertaking of the Company."

Source : BSE - >www.bseindia.com

comment COMMENT NOW